Literature DB >> 169173

Insulin receptors in the heart muscle. Demonstration of specific binding sites and impairment of insulin binding in the plasma membrane of the obese hyperglycemic mouse.

M E Forgue, P Freychet.   

Abstract

The presence of insulin receptors in the heart muscle was investigated by measuring the binding of 125I-insulin to specific subcellular fractions of the rat and mouse myocardium. 125I-insulin bound to the plasma membrane fraction with a high degree of specificity and affinity. Insulin analogues competed with 125I-insulin in direct proportion to their biologic potency in vitro. Unlabeled insulin within the range of its concentrations in vivo inhibited 15 to 60 per cent of the 125I-insulin binding. The specific binding sites were finite in number and represented about 90 per cent of the total binding. The insulin-binding capacity of the plasma membrane fraction was twelve- to fifteenfold higher than that of the mitochondrial fraction. As in the liver, the binding was time- and temperature-dependent with a slower but higher binding achieved at a lower temperature. The binding sites appeared to be heterogeneous with respect to affinity. At 5 degrees C., the "higher-affinity" site had a K of about 2 times 10(9) M-1. No more than 10 per cent of the 125I-insulin was degraded by the heart plasma membranes after one hour at 30 degrees C. or twenty-two hours at 5 degrees C. Studies in the obese hyperglycemic (ob/ob) mouse revealed that the insulin binding is impaired in the heart muscle of this animal. Over a wide range of insulin concentrations, the plasma membrane fraction of ob/ob mice bound only 25 to 40 per cent as much insulin as did membranes of the thin littermates, suggesting that, as in the liver, the fat tissue, and the thymic lymphocyte, the number of insulin-binding sites is decreased in the heart of the ob/ob mouse. This defect selectively affected the plasma membrane fraction and could not be explained by differences in membrane purification or insulin-degrading activity. Heart and liver membranes of forty-hour fasted ob/ob mice bound two to three times as much insulin as did membranes of ob/ob mice fed ad libitum. These studies demonstrate and characterize the binding of insulin to heart muscle membranes; they extend to the heart muscle the insulin receptor defect also found in liver membranes and cells, in fat cell membranes, and in thymic lymphocytes of the ob/ob mouse.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169173     DOI: 10.2337/diab.24.8.715

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Cell membrane receptors for cardiac glycosides in the heart.

Authors:  E Erdmann
Journal:  Basic Res Cardiol       Date:  1977 Jul-Aug       Impact factor: 17.165

Review 2.  Interactions polypeptide hormones with cell membrane specific receptors: studies with insulin and glucagon.

Authors:  P Freychet
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

3.  Binding of insulin to isolated nuclei.

Authors:  I D Goldfine; G J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

4.  Specific insulin binding site on T and B lymphocytes as a marker of cell activation.

Authors:  J H Helderman; T B Strom
Journal:  Nature       Date:  1978-07-06       Impact factor: 49.962

5.  Insulin-dependent changes in subcellular distribution of liver insulin receptors in obese Zucker rats.

Authors:  S López; B Desbuquois; M C Postel-Vinay; C Benelli; M Lavau
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 6.  [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].

Authors:  W Gerok
Journal:  Klin Wochenschr       Date:  1979-06-15

Review 7.  Insulin and obesity.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

8.  Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.

Authors:  A Carducci Artenisio; F Ragonese; F Forte; G Saitta; G Perrone; G Lettina; R Campisi; F Consolo
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

9.  Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.

Authors:  R A DeFronzo; V Soman; R S Sherwin; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

Review 10.  The insulin receptor concept and its relation to the treatment of diabetes.

Authors:  G M Ward
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.